Pathogenetic aspects of treatment of patients with genital endometriosis and syndrome of chronic pelvic pain in combination with "proliferative genital syndrome".

In: Medicni perspektivi (Medical perspectives) · 2018 · vol. 23(2) , pp. 97–103 · doi:10.26641/2307-0404.2018.2.133945 · W2811347248
article OA: diamond CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-21

A differentiated treatment approach based on immunohistochemical markers effectively reduced severe and moderate pain, depression, and improved quality of life in women with genital endometriosis and chronic pelvic pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-21 · read from full text

The paper studied the efficiency of a proposed complex treatment approach for patients with genital endometriosis, chronic pelvic pain syndrome, and combined benign genital pathologies, using a differentiated analysis in 85 patients divided into study groups based on severe versus moderate pain (VAS). Immunohistochemical markers ER, PGR, Ki-67, VEGF, and COX-2 were assessed in glandular and stromal tissue, and the authors report that severe pain was eliminated in all patients within 3 months, while moderate pain persisted in 77.65% and by 12 months 16.47% reported moderate pain and 83.53% weak pain (p<0.05). Depression scores on the Hamilton scale decreased over one year (from 11.22±0.5 to 5.98±0.24, p<0.001). This paper is centrally about endometriosis — it focuses on treatment of genital endometriosis combined with chronic pelvic pain syndrome and benign genital conditions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The aim of the work is to ascertain the efficiency of the use of an offered way of the complex treatment of the patients with genital endometriosis and combined benign pathologies of genitals and СРР. A differentiated approach to treatment and analysis of its effectiveness was conducted among the patients of the 1st and 2nd study groups (85 patients) with the severe and moderate pain syndrome according to the VAS scale. On the basis of analysis of immunohistochemical markers ER, PGR, Ki-67, VEGF, COX-2 in glands and in stroma the therapy was developed: Severe pain syndrome was eliminated in all patients within 3 months of treatment. A moderate level of pain was noted in 77.65%, after 12 months of observation in 16.47% of women, the remaining 83.53% noted a weak level of pain by VAS scale (p<0.05). The level of depression dropped (from 11,22±0,5 baseline to 5,98±0,24 in a year, p<0,001) by the Hamilton scale. This indicates the effectiveness of treatment.
Full text 4,724 characters · extracted from oa-doi-fallback · click to expand
Pathogenetic aspects of treatment of patients with genital endometriosis and syndrome of chronic pelvic pain in combination with "proliferative genital syndrome". DOI: https://doi.org/10.26641/2307-0404.2018.2.133945Keywords: genital endometriosis, "proliferative syndrome", СРР, ER, PGR, Ki-67, VEGF, COX, treatmentAbstract The aim of the work is to ascertain the efficiency of the use of an offered way of the complex treatment of the patients with genital endometriosis and combined benign pathologies of genitals and СРР. A differentiated approach to treatment and analysis of its effectiveness was conducted among the patients of the 1st and 2nd study groups (85 patients) with the severe and moderate pain syndrome according to the VAS scale. On the basis of analysis of immunohistochemical markers ER, PGR, Ki-67, VEGF, COX-2 inglands and in stroma the therapy was developed: Severe pain syndrome was eliminated in all patients within 3 months of treatment. A moderate level of pain was noted in 77.65%, after 12 months of observation in 16.47% of women, the remaining 83.53% noted a weak level of pain by VAS scale (p<0.05). The level of depression dropped (from 11,22±0,5 baseline to 5,98±0,24 ina year, p<0,001) by the Hamilton scale. This indicates the effectiveness of treatment. References Moskalenko VF, Gul'chіy OP, Golubchikov MV, et al. [Biostatistics]. Kyiv, Kniga plyus. 2009;184. Ukrainian. Guriev TD, Sidorova IS, Unanyan AL. [Combination of leiomyoma and endometriosis]. Moskva, OOO «MIA»; 2012. Russian. Dubossarskaya Y, Dubossarskaya Z. [Syndrome of chronic pelvic pain at the level of cross-disciplinary communication]. Meditsinskie aspekty zdorov'ya zhenshchiny. 2013;3(67):5-16. Russian. Radzinskiy VE., editor. [Women`s consultation: practice manual]. Moskva, GEOTAR-Media; 2009. Russian. Zaporozhchenko MВ. [The combination of leiomyoma and endometriosis in women of reproductive age]. Reproduktivnaya endokrinologiya, 2017;4(36):24-29. Russian. Adamyan LV, editor. [Clinical recommendations for managing patients "Combined benign diseases of the uterus (myoma, adenomyosis, endometrial hyperplasia)"]. Moskva, Clinical guidelines; 2015. Russian. Kuznetsova IV. [Chronic pelvic pain]. Akusherstvo i ginekologiya. 2013;5:91-97. Russian. [The modern approaches to the surgical and post-surgical medicamental management of patients with endometriosis. Resolution of the expert council]. Reproduktivnaya endokrinologiya, 2017;2:8-10. Ukrainian. Harchenko YuA. [Adequate assessment of pain is the pledge of successful treatment]. "Universum: Medicine and Pharmacology". [Internet]. 2014;4(5). Available from: http: //7 niversum.com/ru/med/archive/item/3966. Russian. Kumbak B, et al. 2012 Coexistence of adenomyosis in women operated for benign gynecological diseases Zehra Sema Özkan, Banu Kumbak, Hasan Cilgin, Mehmet Simsek Journal Gynecological Endocrinology. 2012;28:212-5. Buchweitz O, Staebler A, Wülfing P, et al. COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2006;2(124):216-21. Нannemann MM, Alexander HM, Cope NJ. Endometrial hyperplasia: a clinician’s review. Obstet. Gynecol. Reprod. Med., 2010;4(20):116-20. http://dx.doi.org/10.1016/j.ogrm.2010.01.002 De Arellano MLB, Wagner MF, Oldeweme J, et al. Neurotrophin expression is not affected in uteri of women with adenomyosis. Journal of Molecular Neuroscience. 2012;3(47):495-504. Nezhat C, Li A, Abed S. “Strong Association Between Endometriosis and Symptomatic Leiomyomas.” JSLS. 2016;20(3):e2016.00053. Uimari O, Järvelä I, Ryynänen M. “Do symptomatic endometriosis and uterine fibroids appear together?”. J Hum Reprod Sci. 2011;1(4):34-38. Downloads How to Cite Issue Section License Copyright (c) 2018 Medicni perspektivi (Medical perspectives) This work is licensed under a Creative Commons Attribution 4.0 International License. Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site. Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

VAS-pain

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK